Taglich Brothers
- Average 12 Month ROI on "Buy" Recommendations
- 101.428%
- Based on
- 16 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Taglich Brothers
- BGSF, Inc. (NYSE: BGSF) was upgraded by analysts at Taglich Brothers from a "moderate buy" rating to a "strong-buy" rating. (6/23/2025)
- Cosmos Health Inc. (NASDAQ: COSM) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (2/20/2024)
- Super League Enterprise, Inc. (NASDAQ: SLE) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (9/5/2023)
- Biosig Technologies, Inc. (NASDAQ: BSGM) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (4/10/2023)
- DecisionPoint Systems, Inc. (NYSEARCA: DPSI) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (4/6/2023)
